Navigation Links
Novartis highlights extensive data on numerous compounds at ASCO in multiple cancers, including Phase III studies in GIST and myelofibrosis
Date:5/31/2011

ia (Ph+ CML) in chronic phase. The effectiveness of Tasigna for this indication is based on major molecular response and cytogenetic response rates at 12 months. The study is ongoing and further data will be required to determine long-term outcome.

Tasigna® (nilotinib) 200 mg capsules is also approved in more than 90 countries for the treatment of chronic phase and accelerated phase Ph+ CML in adult patients resistant or intolerant to at least one prior therapy, including Gleevec. The effectiveness of Tasigna for this indication is based on hematologic and cytogenetic response rates.

TASIGNA BOXED WARNING and Additional Important Safety InformationTASIGNA (nilotinib) prolongs the QT interval. Sudden deaths have been reported in patients receiving TASIGNA. TASIGNA should not be used in patients with hypokalemia, hypomagnesemia, or long QT syndrome. Hypokalemia or hypomagnesemia must be corrected prior to TASIGNA administration and should be periodically monitored. Drugs known to prolong QT interval and strong CYP3A4 inhibitors should be avoided. Patients should avoid food 2 hours before and 1 hour after taking dose. A dose reduction is recommended in patients with hepatic impairment.

ECGs should be obtained to monitor the QTc at baseline, 7 days after initiation and periodically thereafter, as well as following any dose adjustments.

  • Treatment with TASIGNA can cause Grade 3/4 thrombocytopenia, neutropenia and anemia. Complete blood counts should be performed every 2 weeks for the first 2 months and then monthly thereafter.

  • Caution is recommended in patients with a history of pancreatitis.

  • The use of TASIGNA may result in elevations in bilirubin, AST/ALT and alkaline phosphatase.

  • TASIGNA can cause hypophosphatemia, hypokalemia, hyperkalemia, hypocalcemia and hyponatremia (see Boxed WARNING).

  • The concomitant use of strong CYP3A4 inhibitors or anti-arrhythmic drugs (includ
    '/>"/>

  • SOURCE Novartis Pharmaceuticals Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

    Related medicine technology :

    1. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
    2. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
    3. Emisphere Announces Recruitment of Novartis Phase III Study for Oral Osteoporosis Treatment
    4. Video: Novartis Vaccines and PTA Battle Flu: Public Health Vaccination Initiative Urges Families Lets Fight Flu Together!
    5. More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
    6. Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types
    7. Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership
    8. US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease
    9. Results In The New England Journal Of Medicine Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery
    10. Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia
    11. Novartis Pharmaceuticals Corporation Prevails in Medicaid Pricing Case Before Alabama Supreme Court
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/19/2014)... , Dec. 19, 2014 In ... research and marketing communication tools are essential for ... competitive – consequently consumers, desires, preferences, and unmet ... environment, market research groups across all industries are ... communication tools. However, the adoption of new market ...
    (Date:12/19/2014)... YORK , Dec. 18, 2014 Somewhere ... addressing hearing health was forgotten. But Audicus , ... to hear better this new year. Hearing ... facing the aging population, though it is often unaddressed. ... in four has a hearing aid, mainly due to ...
    (Date:12/19/2014)... 2014 Capnia, Inc. (NASDAQ: ... diagnostics based on its proprietary Sensalyze™ Technology Platform ... financial results for the third quarter and nine ... the completion of our initial public offering (IPO), ... recently initiated CoSense® commercial launch," said Anish Bhatnagar, ...
    Breaking Medicine Technology:Study Uncovers New Tools and Techniques for Understanding Consumer Decision Making 2Audicus Will Help People Resolve to Hear Better in 2015 2Capnia Reports Third Quarter 2014 Financial Results 2Capnia Reports Third Quarter 2014 Financial Results 3Capnia Reports Third Quarter 2014 Financial Results 4Capnia Reports Third Quarter 2014 Financial Results 5Capnia Reports Third Quarter 2014 Financial Results 6Capnia Reports Third Quarter 2014 Financial Results 7Capnia Reports Third Quarter 2014 Financial Results 8
    ... Cylene Pharmaceuticals announced today that it has initiated a ... kinase inhibitor, CX-4945, in patients with advanced solid tumors, ... the oral dose escalating trial are determination of safety, ... the appropriate dose for Phase II trials. In addition, ...
    ... resonance imaging (MRI) is a growing technology providing an ... evaluation of back pain according to an article in ... American Academy of Orthopaedic Surgeons ( http://www.jaaos.org/ ). ... additional technical developments will allow MRI to provide even ...
    Cached Medicine Technology:Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 2Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 3MRI Emerges As Vital Resource in Treatment of Back Pain 2MRI Emerges As Vital Resource in Treatment of Back Pain 3
    (Date:12/21/2014)... December 21, 2014 CannabisClassifieds.com celebrates marijuana’s new ... The only one of its kind, the site has provided ... marijuana for 14 years running. It uniquely combines the ... make cannabis readily available to the masses. Assuring the ... the golden ring of public approval. , Shane ...
    (Date:12/21/2014)... Concept Plus, LLC. a SDB and 8(a) certified IT ... today announced it has been recognized by Washington Technology as ... fastest growing government contracting small businesses by calculating their compound ... the first year that Concept Plus, LLC., participated in the ... compound annual growth rate. “For Concept Plus to be recognized ...
    (Date:12/20/2014)... BambooIndustry.com is a leading eco-friendly bamboo ... its bamboo flooring promotion for the coming 2015. ... suppliers, and offers the best bamboo products and ... promotion, all customers can enjoy a special discount, ... know BambooIndustry.com from press releases. , The bamboo ...
    (Date:12/20/2014)... Weddingshe.com has recently announced its new collection ... of special occasion dresses for the coming new year. ... occasion dresses for global women. Now, all the models ... to 80% off. Among the new items, the model ... Dress) is very popular. What’s more, Weddingshe.com also provides ...
    (Date:12/20/2014)... Dress company LunaDress has recently announced its ... Sale, offering big discounts on all of its special occasion ... to own a perfect wedding gown. If you have no ... come to LunaDress. Many different wedding dress styles and our ... now and enjoy the current special offer, up to 80% ...
    Breaking Medicine News(10 mins):Health News:CannabisClassifieds.com Maintains its “Craigslist for Cannabis” Standing with Website Re-launch 2Health News:Concept Plus, LLC. Named One of Washington Technology’s Fast 50 2Health News:Eco-friendy Bamboo Flooring Manufacturer BambooIndustry.com Introduces Its Bamboo Flooring Promotion for 2015 2Health News:Tons of New-in Winter Sweet 16 Dresses from Weddingshe Online Now 2Health News:2015 Collection of Wedding Dresses from LunaDress Online on Sale Now 2
    ... rapid decline in metabolic activity on a PET scan after ... good local tumor control, according to a study presented by ... Annual Meeting. In addition, the researchers also found that ... PET scan before treatment, the more likely a patient is ...
    ... The Ohio Association of Health Plans (OAHP) today warned ... robust benefits if proposals being considered by Congress as part ... If the reforms proposed by the Senate Finance Committee were ... over five years in the individual market and 24% in ...
    ... Experts on both sides of the Atlantic applaud President ... the European Union (EU) Presidency, for establishing a transatlantic ... growing problem that threatens patient safety and public health ... D.C., President Obama and Prime Minister Reinfeldt joined forces ...
    ... BioSciences, LLC today announced the company will be an ... ) in Las Vegas NV, November 11-13, 2009. Their ... exhibit, showing the latest in leading edge technology in ... and cellular metabolism. , "We are pleased to show ...
    ... Baby changing tables cleaned less often than toilet seats, ... Poor cleaning of restrooms aboard cruise ships raises the ... study. , Norovirus causes about 95 percent of acute ... and 2008, norovirus outbreaks occurred on 66 ships monitored ...
    ... ... oral ingestion, and this is known to cause jitters and crashing effects. Now there,s a new ... pepper. Spray Awake is the world,s first personal energy spray to use capsaicin as a way ... ...
    Cached Medicine News:Health News:Congressional Health Care Reform Proposals Will Make Health Care More Expensive, Less Robust for Ohioans 2Health News:U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat 2Health News:U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat 3Health News:U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat 4Health News:Mineral BioSciences to Attend SupplySide West in Las Vegas 2Health News:Poor Restroom Cleaning Causes Cruise-Ship Sickness 2Health News:New Energy Spray Uses Capsaicin to Deliver Caffeine for Sustained Mental Focus 2
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    Medicine Products: